Resource Library
Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.
Highlights
September 25, 2024
Poster Presentation at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
Poster for KT-621, our first-in-class STAT6 degrader in immunology
Highlights
June 1, 2024
Poster Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Poster for KT-253, our MDM2 degrader in oncology
Highlights
May 22, 2024
Poster Presentation at the American Thoracic Society (ATS) 2024 Annual Meeting
Poster for KT-621, our first-in-class STAT6 degrader in immunology
Immunology
We are addressing the root molecular causes of chronic inflammatory disease.
Platform
Discover more about our cutting-edge toolbox of integrated approaches to accelerate the discovery and development of transformative medicines.
Targeted Protein Degradation
Our leadership in TPD is propelling novel medicines forward.